MetaStat Ownership
| MTST Stock | USD 0.0006 0.0001 14.29% |
MetaStat |
MetaStat Pink Sheet Ownership Analysis
The company recorded a loss per share of 0.61. MetaStat had not issued any dividends in recent years. The entity had 1:15 split on the 8th of October 2015. MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The companys therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MICROTEST INC operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people.The quote for MetaStat is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about MetaStat contact the company at 617-531-6500 or learn more at https://www.metastat.com.Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MetaStat Pink Sheet Analysis
When running MetaStat's price analysis, check to measure MetaStat's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetaStat is operating at the current time. Most of MetaStat's value examination focuses on studying past and present price action to predict the probability of MetaStat's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetaStat's price. Additionally, you may evaluate how the addition of MetaStat to your portfolios can decrease your overall portfolio volatility.